Hershey Co (HSY) Stock Price Today
Aura AI Summary
Key Stats
- $33.72BMarket Cap
- 1,501,709Volume
- Consumer StaplesSector
- $236.2852W High
- $157.6152W Low
- 136 DaysTypical Hold Time
- $38.85BEnterprise Value
- 3.46%Div Yield
- -Trading Activity
Track Hershey Co (HSY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Hershey Co has traded between a low of $157.61 and a high of $236.28, highlighting its annual price range. Buy and sell Hershey Co shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Hershey Co
Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.
Most Recent News
Over 200 companies advance 240+ Alzheimer's drugs, marking a new phase in treatment development
More than 200 companies are actively developing over 240 Alzheimer's disease therapies, with around 20 drugs in late-stage trials and many others in earlier phases. Key players include Eli Lilly, Biogen, Johnson & Johnson, and Eisai, focusing on inno...
Dayton T. Brown opens new Huntsville Test & Qualification Center to boost aerospace and defense testing.
Dayton T. Brown, Inc. inaugurated its new 104,000-square-foot Test & Qualification Center in Huntsville, Alabama, enhancing its capacity to support aerospace, defense, and propulsion programs. The facility's strategic location near Huntsville's aeros...
Sagimet Biosciences starts key Phase 3 trial for acne drug denifanstat in the U.S.
Sagimet Biosciences has initiated a crucial Phase 3 clinical trial in the U.S. for denifanstat, an oral treatment targeting moderate to severe acne. The trial, named AURORA, aims to enroll around 800 patients, including adolescents, to support regula...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.